Clinical Trials Browser

Terminated × Breast Neoplasms × vandetanib × Clear all

NCT01934335 2021-11-01

Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer

Phase 2 Terminated

12 enrolled 10 charts

Breast Neoplasms

NCT00481845 2017-02-07

Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer

Phase 2 Terminated

1 enrolled 8 charts

Breast Neoplasms

NCT00752986 2016-12-05

ZACFAST

Phase 2 Terminated

39 enrolled 7 charts

Breast Neoplasms, Neoplasm Metastasis